• Privacy policy
  • T&C’s
  • About Us
    • FAQ
    • Meet the Team
  • Contact us
TLE ONLINE SHOP!
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
  • JOBS
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
  • JOBS
No Result
View All Result
The London Economic
No Result
View All Result
Home Lifestyle Health

First drug to prevent Alzheimer’s disease has been created

It boosts a chemical that clears the brain of rogue proteins that cause memory loss and confusion.

Jim Leffman by Jim Leffman
2020-01-22 01:00
in Health, Lifestyle
Photo: PA

Photo: PA

FacebookTwitterLinkedinEmailWhatsapp

The first drug to prevent Alzheimer’s disease has been created by scientists.

It boosts a chemical that clears the brain of rogue proteins that cause memory loss and confusion.

Mice prone to the disorder remained free of it after being injected with the compound.

It is hoped the revolutionary medicine will slow or even reverse dementia in humans. Trials are already being planned.

Currently, there are no treatments that can do this. Existing ones only help with symptoms.

Known as a ‘pharmacological chaperone’, it mends mutant proteins called amyloid beta and tau that misfold in the grey matter of patients.

Explained senior investigator Professor Domenico Pratico: “Our chaperone drug specifically restored levels of a sorting molecule known as VPS35, which helps move proteins out of endosomes, compartments inside cells where proteins are sorted for degradation.”

RelatedPosts

Lucky Numbers and Horoscopes for today 5 July 2022

Lucky Numbers and Horoscopes for today 4 July 2022

Lucky Numbers and Horoscopes for today 3 July 2022

Lucky Numbers and Horoscopes for today 2 July 2022

His team previously found VPS35 actively sweeps out amyloid beta and tau that can collect in clumps and tangles, respectively, destroying neurons.

In Alzheimer’s, levels are reduced. Eventually, these deposits of abnormal proteins interrupt neuron activity and lead to brain degeneration.

In experiments, lab rodents genetically engineered to develop the disease were treated with the drug from a young age.

As they got older, before they began to show signs of it, they were tested for its effects on memory and learning.

Normal mice

Compared to untreated peers destined for Alzheimer’s, they did much better – and behaved just like normal mice in the wild.

An analysis of their neurons found much less tau and amyloid beta that fuel the disease.

The researchers also found the amount of VPS35 was restored. What is more junctions, or synapses, where brain cells come together to exchange information, were fully functional.

Prof Pratico, director of the Alzheimer’s Centre at Temple University, Philadelphia, said pharmacological chaperones are an emerging therapy that target proteins that “crumple together like sticky tape.”

When this happens, rather than being transported to recycling sites within cells, old or dysfunctional proteins become trapped. Eventually, they gum up cellular machinery, causing major problems.

Fortunately, cells are equipped with molecular machinery that detects defective proteins, sorts them out, and then either removes or stabilises them, stopping accumulation and harm.

Pharmacological chaperones can help in this process.

Prof Pratico said: “Relative to other therapies under development for Alzheimer’s disease they are inexpensive, and some have already been approved for the treatment of other diseases.

“Additionally, these drugs do not block an enzyme or a receptor but target a cellular mechanism, which means that there is much lower potential for side effects.

“All these factors add to the appeal of pursuing pharmacological chaperones as novel Alzheimer’s treatments.”

Abnormal processes

The study published in the journal Molecular Neurodegeneration shows one such drug can effectively disrupt the abnormal processes that damage neurons in the brain, cause memory loss and ultimately give rise to Alzheimer’s.

The trafficking of proteins from endosomes to the cell membrane or another cellular compartment is fundamental for normal cell function.

Prof Pratico said VPS35 is of particular importance, since it separates out dysfunctional and old proteins and sends them off for recycling.

Before moving to trials in patients, he wants to next investigate the effects of pharmacological chaperone therapy in older mice.

Added Prof Pratico: “Because our most recent investigation was a preventative study, we want to know now whether this therapy could also work as a treatment for patients already diagnosed with Alzheimer’s disease.”

There haven’t been any new dementia drugs in over a decade. Currently, there are an estimated 850,000 people with the condition in the UK, a figure set to rise to 2 million in the next three decades.

Related – Alzheimer’s could be predicted by brain scan…decades before symptoms develop

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

Trending on TLE

  • All
  • trending
Abdollah

‘Rescue us’: Afghan teacher begs UK to help him escape Taliban

CHOMSKY: “If Corbyn had been elected, Britain would be pursuing a much more sane course”

What If We Got Rid Of Prisons?

More from TLE

Liverpool FC condemns fans’ behaviour amid league title celebrations

Boy with autism gets dream tour of a rail depot after staff discovered he learned to talk reading train timetables

Newspapers react as Tories plan tax grab to fund social care

Tory Britain: Where child poverty soars as the rich get richer

Huge crowds take to streets to demand urgent climate action

Set For Life Results for Monday 20 June 2022 Tonight’s winning numbers

Man jailed after he repeatedly spat at police & claimed he had coronavirus

Optimism about immigration?

Express confuses Raducanu for Fernandez in article defending Leave voters

‘Snobby’ residents left note saying Skoda ‘makes the street look like Beirut’

JOBS

FIND MORE JOBS

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.




No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Meet the Team
    • Privacy policy
  • Contact us

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.